Literature DB >> 22440489

Renal denervation for hypertension.

Stefan C Bertog1, Paul A Sobotka, Horst Sievert.   

Abstract

Systemic hypertension is a major burden to the individual and society. Its association with major adverse cardiac and cerebral events and favorable effects of antihypertensive therapy are undisputed. However, despite multidrug therapy, blood pressures are frequently suboptimally controlled. Moreover, adverse drug effects often interfere with patients' lifestyles and affect compliance. Therefore, alternative treatment strategies have been explored. Most recently, attention has been redirected to the sympathetic nervous system (SNS) in the pathogenesis of hypertension. In addition, interruption of the renal SNS in humans with resistant hypertension has been studied with promising results. The following review provides an overview of the anatomy and physiology of the renal SNS, the rational for manipulating the SNS, and the results of therapeutic renal sympathetic denervation.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22440489     DOI: 10.1016/j.jcin.2011.12.011

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  16 in total

1.  Renal denervation in the treatment of resistant arterial hypertension.

Authors:  Thomas Lambert; Wilhelm Schützenberger; Clemens Steinwender
Journal:  Wien Med Wochenschr       Date:  2014-11-14

2.  Renal sympathetic denervation in resistant hypertension.

Authors:  Mário Santos; Henrique Carvalho
Journal:  World J Cardiol       Date:  2013-04-26

Review 3.  Device-Based Therapy for Drug-Resistant Hypertension: An Update.

Authors:  Ping Li; Mark Nader; Kousalya Arunagiri; Vasilios Papademetriou
Journal:  Curr Hypertens Rep       Date:  2016-08       Impact factor: 5.369

Review 4.  Renal denervation: intractable hypertension and beyond.

Authors:  Wassawon Ariyanon; Huijuan Mao; Zelal Adýbelli; Silvia Romano; Mariapia Rodighiero; Bernhard Reimers; Luigi La Vecchia; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2014-01-15       Impact factor: 2.041

Review 5.  Transcatheter therapies for resistant hypertension: Clinical review.

Authors:  Adil Lokhandwala; Abhijeet Dhoble
Journal:  World J Cardiol       Date:  2014-08-26

Review 6.  Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?

Authors:  Luke J Laffin; George L Bakris
Journal:  Am J Hypertens       Date:  2017-09-01       Impact factor: 2.689

7.  Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea).

Authors:  B-K Kim; M Böhm; F Mahfoud; G Mancia; S Park; M-K Hong; H-S Kim; S-J Park; C G Park; K B Seung; H-C Gwon; D-J Choi; T H Ahn; C J Kim; H M Kwon; M Esler; Y S Jang
Journal:  J Hum Hypertens       Date:  2015-07-09       Impact factor: 3.012

Review 8.  The role of renal denervation for the treatment of resistant hypertension.

Authors:  A J A McLellan; P M Kistler; A S Walton; M P Schlaich
Journal:  J Hum Hypertens       Date:  2013-10-03       Impact factor: 3.012

Review 9.  Renal Denervation for Patients With Atrial Fibrillation.

Authors:  Arwa Younis; Jonathan S Steinberg
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

Review 10.  Where and when device therapy may be useful in the management of drug-resistant hypertension.

Authors:  Herbert D Aronow; Jun Li; Sahil A Parikh
Journal:  Curr Cardiol Rep       Date:  2014-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.